Analysts Set Axon Enterprise, Inc. (NASDAQ:AXON) PT at $504.92

Shares of Axon Enterprise, Inc. (NASDAQ:AXON) have received a consensus rating of “Buy” from the fourteen analysts that are covering the company, MarketBeat.com reports. Fourteen research analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have covered the stock in the last year is $524.85.

A number of research analysts have weighed in on AXON shares. The Goldman Sachs Group lifted their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Finally, Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th.

Insider Buying and Selling

In other news, President Joshua Isner sold 20,000 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the sale, the president now owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock worth $30,721,337 in the last quarter. 6.10% of the stock is owned by insiders.

Institutional Trading of Axon Enterprise

Institutional investors have recently made changes to their positions in the stock. Global Retirement Partners LLC raised its holdings in Axon Enterprise by 23.1% during the 4th quarter. Global Retirement Partners LLC now owns 974 shares of the biotechnology company’s stock valued at $579,000 after buying an additional 183 shares during the last quarter. Bank of Jackson Hole Trust purchased a new position in shares of Axon Enterprise in the fourth quarter valued at about $79,000. Venturi Wealth Management LLC raised its stake in shares of Axon Enterprise by 2.7% during the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after acquiring an additional 21 shares during the last quarter. CIBC Asset Management Inc boosted its holdings in shares of Axon Enterprise by 127.0% during the fourth quarter. CIBC Asset Management Inc now owns 24,013 shares of the biotechnology company’s stock worth $14,271,000 after purchasing an additional 13,435 shares during the period. Finally, Strategic Advisors LLC bought a new stake in shares of Axon Enterprise in the fourth quarter worth about $254,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $652.18 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise has a one year low of $247.04 and a one year high of $698.67. The firm has a market capitalization of $49.73 billion, a P/E ratio of 168.52, a PEG ratio of 6.41 and a beta of 1.04. The business has a fifty day moving average price of $619.63 and a 200-day moving average price of $481.39.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.